Corsair Capital Management’s Precigen PGEN Stock Holding History

Corsair Capital Management’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-20,000	Closed	-$23K	–	114
2023 Q2	$23K	Buy	+20,000	New	+$23.6K	0.01%	103

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Corsair Capital Management's PGEN Position: Q3 2023 in Review

Corsair Capital Management sold out of Precigen (PGEN) in Q3 2023, closing a stake of 20,000 shares — an estimated $23K sold.

Corsair Capital Management first reported a position in PGEN in Q2 2023 and held it in 1 quarter. The position peaked at $23K in Q2 2023. 138 funds tracked by Wall St. Rank hold PGEN as of Q3 2023.

Corsair Capital Management reported no remaining Precigen position as of Q3 2023 after selling out during the quarter.
Corsair Capital Management sold 20,000 Precigen shares in Q3 2023, an estimated $23K.
Corsair Capital Management first reported a position in Precigen in Q2 2023 and held it in 1 quarter.
Corsair Capital Management's Precigen position peaked at $23K in Q2 2023.
138 funds tracked by Wall St. Rank held Precigen as of Q3 2023.

Based on Corsair Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.